Aktis Oncology shares surge 28.78% intraday on Nasdaq debut after upsized $318M IPO and strong institutional demand.

think> Okay, let's start by understanding the user's request. They want me to act as a financial analyst explaining a stock price movement based on relevant news events. The stock in question is Aktis Oncology, which saw a 28.78% intraday increase. The task is to link this movement with the provided news events and summarize it in a Bloomberg-style paragraph. First, I need to check the stock performance details. The stock went up by 28.78% during intraday trading. The key point here is the timing—this is during regular trading hours, not pre-market or after-hours. Next, I'll look at the news events provided. There are six reasons listed. Let me go through each one to determine relevance and direction. Reason 1: Aktis Oncology shares surged 50% in Nasdaq debut. The summary mentions the IPO price was $18, and the opening at $27. This is a significant jump. The content also talks about an upsized IPO, with Eli Lilly investing $100M. This seems relevant and positive. The stock movement mentioned here is a 50% increase, which is higher than the 28.78% reported. But since the user's input says intraday up 28.78%, maybe the actual trading session's peak was lower than the opening surge. However, the IPO debut is a major event. Reason 2: Aktis Oncology soars in debut after upsized $318 million IPO. The summary states shares jumped as much as 62% in their Nasdaq debut. Again, this is another report of the IPO success. The content is minimal, but the headline is clear. This is another positive event. Reason 3: ITS to provide pre-market trading in Aktis Oncology U.S. IPO. This is about pre-market access starting on January 9, 2026. The IPO is scheduled for that date. However, the stock's movement is intraday, so this news might be about the timing of the IPO but not directly causing the price movement unless the IPO was on the same day. Wait, the user's input says the trading period is intraday, but the news here mentions the IPO is scheduled for January 9, 2026. If the stock's movement is on that day, then this news would be relevant. However, the user's input doesn't specify the date of the stock movement. The news event is about the IPO date being January 9, so if the stock's intraday movement is on that day, then this news is relevant. However, the user's input doesn't provide the date of the stock movement. Hmm, this might be a problem. But the user's example input had a specific date, so maybe the user expects us to assume that the stock movement is on the same day as the IPO. Given that the news mentions the IPO is scheduled for January 9, 2026, and the stock's movement is intraday, it's possible that the movement is on that day. Therefore, this news is relevant as it's about the IPO date and pre-market trading. Reason 4: Aktis Oncology IPO said to end 10 times oversubscribed. This indicates strong investor demand, which is positive. Oversubscribed IPOs usually lead to higher opening prices. This supports the stock's upward movement. Reason 5: Aktis Oncology Prices IPO; Shares Set for Nasdaq Debut. This is about the IPO pricing at $18 and the expected trading date. If the stock opened at $27, this news would be relevant as it confirms the IPO details. Reason 6: Aktis Oncology opens at $27, IPO at $18. This is a direct confirmation of the opening price versus the IPO price, which is a 50% increase. This is a key event. Now, the user's input says the stock's intraday movement was up 28.78%. However, the news events mention a 50% jump (Reason 1), 62% (Reason 2), and others. The discrepancy here might be due to the difference between the opening price and the intraday peak. The stock opened at $27 (50% above $18) but might have fluctuated during the day. The user's input is 28.78%, which is lower than 50%, so perhaps the stock opened higher but then retreated a bit. However, the main cause of the movement is the IPO debut and the associated factors. The relevant news events are all related to the IPO: the upsized offering, strong investor demand (10 times oversubscribed), pre-market trading arrangements, and the lead investor (Eli Lilly). These factors contributed to the stock's surge. The key points to include are the IPO details, the upsized offering.